Why Cerberus Cyber Sentinel Shares Are Trading Higher By 147%; Here Are 20 Stocks Moving Premarket



  • Cerberus Cyber Sentinel Corporation CISO shares rose 147% to $0.5682 in pre-market trading. Cerberus Cyber Sentinel said it sees Q4 revenue of $14.7 million and sees FY22 revenue of $46.5 million.
  • Blue Star Foods Corp. BSFC climbed 29.9% to $0.2061 in pre-market trading after jumping around 22% on Monday.
  • Pear Therapeutics, Inc.. PEAR gained 24.1% to $0.26 in pre-market trading after dropping 46% on Monday. Pear Therapeutics, last week, said it is exploring strategic alternatives and said it may seek a reorganization if it is unable to complete a transaction.
  • First Republic Bank FRC rose 20.6% to $14.69 in pre-market after dropping 47% on Monday. Jamie Dimon, CEO at JPMorgan Chase & Co. JPM, is leading talks with other leaders of prominent banks to resolve the First Republic crisis, the Wall Street Journal reported on Monday.
  • Bird Global, Inc. BRDS gained 17.6% to $0.13 in pre-market trading after declining 8% on Monday. Bird Global recently reported better-than-expected Q4 sales results.
  • Catalyst Biosciences, Inc. CBIO gained 16.6% to $0.22 in pre-market trading. GC Biopharma recently signed an Asset Purchase Agreement with the company.
  • Aurora Innovation, Inc. AUR shares rose 15.7% to $1.33 in pre-market trading after dropping around 9% on Monday.
  • Selecta Biosciences, Inc. SELB shares rose 14.1% to $1.46 in pre-market trading. Selecta Biosciences said Phase 3 DISSOLVE program of SEL-212 in chronic refractory gout met primary endpoint.
  • Novo Integrated Sciences, Inc. NVOS shares rose 13.4% to $0.1150 in pre-market trading.
  • Edible Garden AG Incorporated EDBL rose 11.2% to $4.11 in pre-market trading after gaining 14% on Monday. Edible Garden is scheduled to host a conference call on March 22, 2023 to discuss financial results for the quarter ended Dec. 31, 2022.


  • Qutoutiao Inc. QTT fell 64.2% to $0.25 in pre-market after gaining 3% on Monday.
  • PainReform Ltd. PRFX fell 23.8% to $0.4213 in pre-market trading. PainReform announced commencement of Phase 3 clinical trial to evaluate PRF-110 in patients undergoing bunionectomy surgery.
  • First Majestic Silver Corp. AG fell 17.1% to $6.17 in pre-market trading. First Majestic Silver temporarily suspended mining activities and reduced its workforce at Jerritt Canyon, which represented 21% of the company's 2022 revenue.
  • Iveda Solutions, Inc. IVDA shares dropped 12.8% to $0.95 in pre-market trading after gaining over 5% on Monday.
  • Boxed, Inc. BOXD fell 12.3% to $0.1202 in pre-market trading after jumping over 35% on Monday.
  • Connect Biopharma Holdings Limited CNTB fell 12.1% to $1.16 in pre-market trading after gaining 20% on Monday. Connect Biopharma announced post hoc data analysis from the Phase 2b CBP-201 global trial in moderate-to-severe atopic dermatitis (AD).
  • ThermoGenesis Holdings, Inc. THMO fell 11.7% to $3.93 in pre-market trading. ThermoGenesis closed $3 million private placement priced at-the-market under NASDAQ rules.
  • Allarity Therapeutics, Inc. ALLR shares fell 11.2% to $0.1278 in pre-market trading. Allarity Therapeutics shares jumped 37% on Monday after the company said it dosed the first patient in its trial studying advanced solid tumors.
  • Lichen China Limited LICN fell 11.1% to $1.90 in pre-market trading.
  • Gelesis Holdings, Inc. GLS shares fell 9.5% to $0.1900 in pre-market trading after jumping over 90% on Monday.

Now Read This: Fear & Greed Index Remains In 'Fear' Zone; US Stocks Settle Higher

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasIndustrialsPremarket MoversTop GainersTrading Companies & Distributors
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!